26 phenotypes from 2 alleles in 4 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Nfe2tm1.1Hlpa/? involves: 129 * C57BL/6	increased acute myeloid leukemia incidence	J:275444
	increased myeloid sarcoma incidence	J:275444
Nfe2tm1Sho/Nfe2+ C.129S4-Nfe2tm1Sho	enlarged spleen	J:125982
	increased incidence of induced tumors	J:125982
	increased susceptibility to induced morbidity/mortality	J:125982
	increased susceptibility to Retroviridae infection	J:125982
Nfe2tm1Sho/Nfe2tm1Sho involves: 129/Sv * 129S4/SvJae	abnormal hematopoietic system physiology	J:20132, J:106670
	abnormal megakaryocyte morphology	J:20132, J:106670
	absent platelets	J:20132
	anemia	J:20132
	decreased body size	J:20132
	decreased hemoglobin content	J:20132
	decreased survivor rate	J:20132
	increased bone ossification	J:111270
	increased compact bone mass	J:111270
	increased megakaryocyte cell number	J:20132
	increased osteoblast cell number	J:111270
	increased osteoclast cell number	J:111270
	increased trabecular bone volume	J:111270
	internal hemorrhage	J:20132
	microcytosis	J:20132
	neonatal lethality, incomplete penetrance	J:20132
	pallor	J:20132
	postnatal lethality, incomplete penetrance	J:20132
	thrombocytopenia	J:106670
Nfe2tm1Sho/Nfe2tm1Sho involves: 129S4/SvJae * C57BL/6J	abnormal hematopoietic system physiology	J:20132
	abnormal megakaryocyte morphology	J:20132
	absent platelets	J:20132
	anemia	J:20132
	decreased body size	J:20132
	decreased hemoglobin content	J:20132
	decreased survivor rate	J:20132
	enhanced megakaryocyte emperipolesis	J:20132
	increased megakaryocyte cell number	J:20132
	internal hemorrhage	J:20132
	microcytosis	J:20132
	neonatal lethality, incomplete penetrance	J:20132
	pallor	J:20132